NCT00340327已完成1 期
An Ascending Single Dose Study of the Safety and Pharmacokinetics of IMA-638 Administered to Healthy Japanese Subjects
Wyeth is now a wholly owned subsidiary of Pfizer1 个研究点 分布在 1 个国家开始时间: 2006年6月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 试验地点
- 1
- 主要终点
- Safety will be measured by evaluating physical examinations, vital signs, electrocardiograms (ECGs), and clinical laboratory test results.
研究概览
简要总结
The purpose of this study is to evaluate the safety and drug levels for single, ascending doses of IMA-638 in healthy Japanese subjects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- Double
入排标准
- 年龄范围
- 20 Years 至 45 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •First generation healthy Japanese men and women of non-childbearing potential.
排除标准
- 未提供
结局指标
主要结局
Safety will be measured by evaluating physical examinations, vital signs, electrocardiograms (ECGs), and clinical laboratory test results.
次要结局
- Drug levels and associated biomarkers will be evaluated.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's DiseaseParkinson's Disease (PD)NCT03033498AbbVie29
已完成
1 期
Study Evaluating The SBI-087 In Subjects With Systemic Lupus ErythematosusLupus Erythematosus, SystemicNCT00714116Pfizer30
已完成
1 期
A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy VolunteersChemotherapy-induced Nausea and VomitingNCT02382666Tesaro, Inc.100
已完成
1 期
A Study of MK-5720 in Participants With Schizophrenia (MK-5720-001)SchizophreniaNCT05953740Merck Sharp & Dohme LLC17
已完成
1 期
A Safety and Pharmacokinetics Study of ZB004 in Healthy ParticipantsHealthy VolunteersNCT05794516Zenas BioPharma (USA), LLC40